Tissue regeneration technology developer Orthocell has received Food and Drug Administration approval to market its first product in the US, its CelGro Dental collagen device which aids dental bone and tissue regeneration. The Perth company announced the approval and a new brand name for the products, Striate+. Managing director Paul Anderson said CelGro would now…
Nerve technology developer Orthocell (ASX:OCC) has received a $2.9 million R&D tax incentive refund for the 2018/19 financial year. The Perth company, which is commercialising its CelGro product to facilitate the regeneration of severed peripheral nerves, will invest the funds to accelerate regulatory approvals and to advance R&D. The company also recently raised new capital…
Nerve technology developer Orthocell (ASX:OCC) has received firm commitments from institutional investors to raise $13 million in a share placement. The company, which is commercialising its CelGro nerve regeneration product, received commitments for well in excess of the figure sought from existing and new investors. The company will also proceed with a share purchase plan…
Nerve technology developer Orthocell (ASX:OCC) has reported a study validating ‘high quality nerve repair’ from its CelGro treatment. The pre-clinical study indicated CelGro facilitated the regeneration of severed peripheral nerves, returning them to normal nerve structure. This reinforces earlier human trials that CelGro restored nerve sensation, reducing the need for sutures. Orthocell managing director, Paul…
Element 25’s manganese gets $US 166 million grant ASX-listed minerals company Element 25 has announced that a grant agreement has been signed for $US 166 million ($268 million) in funding from the U.S. Department of Energy (DoE) under the Battery Materials Processing Grant Program. The funding will support construction of a proposed battery-grade high-purity manganese…
ARE receives $5m grant for rare earths development Australian Rare Earths has received a $5 million grant from the federal government’s International Partnerships in Critical Minerals Program. The funding will support additional metallurgical test work, completion of a pre-feasibility study and building/operating a demonstration plant at the company’s Koppamurra project, a frontier ionic clay rare…
Rhythm receives R&D tax incentive refund Predictive cancer diagnostics technology company Rhythm Biosciences has received multiple tranches of its research and development tax incentive (RDTI), totalling $3.23 million. This total is made up of approximately $1.24 million in relation to FY23, being a second tranche of funds following the submission of an amended FY23 tax…
Aurora Labs lands third defence PO Metal additive manufacturer Aurora Labs has received its third direct order from the Australian Department of Defence for advanced 3D-printed metal components. The order valued at $50,000 strengthens the strategic relationship between A3D and Defence, according to an announcement. The CEO of Aurora Labs Rebekah Letheby said: “This third…
GreenHY2 receives first grant funding for Telstra project Hydrogen Energy storage manufacturer GreenHY2 has received the 1st Instalment of the grant funds allocated by the federal government to provide its Hy2MEDI generation and storage system to Telstra. The amount received is $432,000 plus GST, with the total grant for the project valued at $1.5 million.…
GreenHy2 to provide hydrogen power generation, storage to Telstra Hydrogen energy storage manufacturer GreenHy2 has signed a Federal Government Grant to provide its Hy2MEDI generation and storage system to Telstra. The System, valued at $1.5 million, will be funded by the Australian Government from the Telecommunications Disaster Resilience Innovation (TDRI) Program, Power Resilience Round. GreenHy2…
